Patients on antibiotics are seven to 10 times more likely
to get Clostridioides difficile
infection (CDI) while on the drugs and during the month after. With the rise of CDI incidence in community and acute-care settings, patients may not initially present to a GI specialist. It’s more important than ever that clinicians learn effective methods for early intervention, treatment and recurrence prevention.
Complete AGA’s program to earn up to 3.5 AMA PRA Category 1 CreditsTM
and hear innovative perspectives to help you identify and overcome everyday challenges, including how to:
This activity is supported by an independent educational grant from Merck & Co, Inc.
- Identify early signs of mild to moderate CDI based on patient risk factors and use and misuse of antibiotic therapy.
- Evaluate patients with CDI who may be at high risk of recurrence through appropriate assay analysis.
- Outline evidence-based approaches, including better antimicrobial stewardship, for initial and recurrent episodes of CDI.
- Recommend treatment strategies for the prevention of recurrent CDI.
- Explore Series